These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21252243)

  • 1. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes.
    Sung KC; Kim SH
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1093-7. PubMed ID: 21252243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.
    Sung KC; Jeong WS; Wild SH; Byrne CD
    Diabetes Care; 2012 Apr; 35(4):717-22. PubMed ID: 22338098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
    Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study.
    Goldberg RB; Tripputi MT; Boyko EJ; Budoff M; Chen ZZ; Clark JM; Dabelea DM; Edelstein SL; Gerszten RE; Horton E; Mather KJ; Perreault L; Temprosa M; Wallia A; Watson K; Irfan Z
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4746-e4765. PubMed ID: 33705543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study.
    Flores-Guerrero JL; Connelly MA; Shalaurova I; Gruppen EG; Kieneker LM; Dullaart RPF; Bakker SJL
    J Clin Lipidol; 2019; 13(1):129-137.e1. PubMed ID: 30591414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Moh Moh MA; Jung CH; Lee B; Choi D; Kim BY; Kim CH; Kang SK; Mok JO
    Diab Vasc Dis Res; 2019 Mar; 16(2):186-195. PubMed ID: 30428692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
    Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
    Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study.
    Sato KK; Hayashi T; Maeda I; Koh H; Harita N; Uehara S; Onishi Y; Oue K; Nakamura Y; Endo G; Kambe H; Fukuda K
    Clin Endocrinol (Oxf); 2014 Mar; 80(3):362-7. PubMed ID: 23418907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of nonalcoholic fatty liver disease with insulin resistance.
    Marchesini G; Brizi M; Morselli-Labate AM; Bianchi G; Bugianesi E; McCullough AJ; Forlani G; Melchionda N
    Am J Med; 1999 Nov; 107(5):450-5. PubMed ID: 10569299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-sensitive adiposity is associated with a relatively lower risk of diabetes than insulin-resistant adiposity: the Bogalusa Heart Study.
    Zhang T; Li Y; Zhang H; Sun D; Li S; Fernandez C; Harville E; Bazzano L; He J; Chen W
    Endocrine; 2016 Oct; 54(1):93-100. PubMed ID: 27060004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
    Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
    JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study.
    Hanley AJ; Williams K; Festa A; Wagenknecht LE; D'Agostino RB; Kempf J; Zinman B; Haffner SM;
    Diabetes; 2004 Oct; 53(10):2623-32. PubMed ID: 15448093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study.
    Zhang M; Wang B; Liu Y; Sun X; Luo X; Wang C; Li L; Zhang L; Ren Y; Zhao Y; Zhou J; Han C; Zhao J; Hu D
    Cardiovasc Diabetol; 2017 Mar; 16(1):30. PubMed ID: 28249577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution.
    Haffner SM; Stern MP; Mitchell BD; Hazuda HP; Patterson JK
    Diabetes; 1990 Mar; 39(3):283-8. PubMed ID: 2407581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans.
    Lee JW; Lim NK; Park HY
    BMC Endocr Disord; 2018 May; 18(1):33. PubMed ID: 29843706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance.
    Lilja M; Rolandsson O; Norberg M; Söderberg S
    Metab Syndr Relat Disord; 2012 Apr; 10(2):143-51. PubMed ID: 22283633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor 3 is associated with insulin resistance and with incident type 2 diabetes over a 7-year follow-up period: the CODAM Study.
    Wlazlo N; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schalkwijk CG; Bravenboer B; Stehouwer CD
    Diabetes Care; 2014 Jul; 37(7):1900-9. PubMed ID: 24760264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.